New Market Research Report: Healthcare, Regulatory and Reimbursement Landscape - Thailand


Fast Market Research recommends "Healthcare, Regulatory and Reimbursement Landscape - Thailand" from GlobalData, now available


Published on 14 March 2013

by Bill Thompson

(WireNews+Co)

Boston, MA

Industry analysis specialist GlobalData has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Thailand". An essential source of information and analysis on the Thai healthcare, regulatory and reimbursement landscape, it identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, and reimbursement landscape and healthcare infrastructure.
Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

View Full Report Details and Table of Contents (http://www.fastmr.com/prod/553266_healthcare_regulatory_and_reimbursement_landscape.aspx?afid=201)

In 2011, the population of Thailand was 64.1 million. In 2011, the pharmaceutical market was estimated to be worth $4.2 billion and is expected to reach $8.9 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 8.9%. The medical device market was worth approximately $875.1m in 2011 and is expected to reach $1.8 billion by 2020 at a CAGR of 8%.

The positive trends in Thailand's healthcare market can primarily be attributed to -

- Increasing medical tourism Increasing health awareness
- Greater access to life-saving facilities

Scope

The report provides information on Thailand's healthcare, regulatory and reimbursement landscape, including -

- Overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market. The key players covered are Pfizer, Merck, Sanofi-Aventis, GlaxoSmithKline (GSK), Novartis, Government Pharmaceutical Organization (GPO), Biolab, and Greater Pharma
- Insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices
- Detailed analysis of Thailand's political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the healthcare market.

Reasons to buy

The report will enhance your decision-making capability and allow you to -

- Develop business strategies by understanding the trends shaping and driving the healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
-


Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget.  For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.


Contacts

  •  
  • Bill Thompson
  • Fast Market Research, Inc.
  • PR Contact
  • Tel: +14134857001
  •  
Enter your email:
Enter Subject:
Enter your message:
Please enter this numbers in the fields:
 
  Click image to get a new code.
Enter code:
 

Posted 2013-03-14 17:16:00